The above chart presents the market trend analysis for ferring pharmaceiticals inc from 2022 to 2023.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
YearTransactionsQuantityWeight
Bill of lading data
<
1/15
>
Trade date
2022/12/12
B/L No.
dsvf970573
Supplier
biotechnology general israel ltd.
Buyers
ferring pharmaceiticals inc
ferring pharmaceiticals inc is united states Buyer,
and primarily engages in the import and export business of products such as flex.
According to the 52wmb.com global trade database, as of 2022-12-12, the company has completed 46 international trades,
with its main trading regions covering israel,china,other etc.
often transported via savannah ga,port charleston, port new york etc,
and its main trading partners are biotechnology general israel ltd.,ferring pharmaceutical china,bio technologies general ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on ferring pharmaceiticals inc is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.